About The Role

Getting to know GH&B

Global Hospital & Biosimilars (GH&B) makes the products that are the foundation of hospital care — sterile injectables and biosimilars – that reach more than 100 million patients annually, generating $5 billion in revenue for Pfizer. These are not niche products; they are for when patients are at the most vulnerable, essential to access and acute care delivery worldwide.
GH&B is Pfizer's only truly end-to-end business, spanning from our 12 global manufacturing sites through to commercial in a single integrated organization. It was created to give this portfolio dedicated focus, clearer accountability, and a fit-for-purpose operating model — recognizing that GH&B's portfolio has different economics, customer dynamics, and execution needs than Pfizer's innovative business.
By bringing Commercial and Supply into one organization, GH&B enables faster decision-making, stronger prioritization, and expanded capabilities for this important portfolio.
Our ambition: Rebuild a healthy operation positioned to serve patients for generations to come

Own the full P&L (~$321M) across multiple Asian markets; set strategic direction across markets; manage varying revenue growth trajectories and margin profiles
Allocate resources and prioritize portfolio investments across cluster markets based on growth potential, competitive intensity, and portfolio mix as well as maturity
Calibrate investment between larger markets' scale and growth potential in smaller or partner-led markets
Represent cluster in global planning cycles (OP/LE, QBRs, strategic reviews)

Set commercial direction for in-market assets across all cluster markets while identifying growth opportunities via portfolio expansion, including upcoming launches
Ensure contract excellence and pricing discipline across diverse tender and negotiation environments
Shape field force effectiveness and customer engagement standards across Account Management and T&C teams, including oversight of partner/distributor-led execution models
Navigate complex and diverse payer and procurement systems across the cluster — including government tenders, provincial quota-setting systems, national e-catalogue procurement, and direct hospital-level negotiations
Drive higher emphasis on branding and marketing capabilities in Asian markets to support differentiation
Manage CSO/distribution partnerships as well as SLA governance (scope, KPIs, transition triggers)

Serve as the face of Pfizer GH&B to local external stakeholders — governments, regulators, payers, KOLs, and industry bodies in conjunction with the innovative medicines group as relevant?
Navigate complex and divergent stakeholder systems across the cluster markets, including government tender authorities, hospital procurement bodies, and local distribution partners
Coordinate with global functions (Medical, Regulatory, Supply) and serve as escalation point for platform support
Collaborate with the broader Pfizer organization to align with the Innovative portfolio and secure resources and functional support (Medical, Finance, Legal, Compliance, GAV)

Lead multiple colleagues across all cluster markets, including distributed teams not co-located with you
Direct oversight of regional Portfolio Management & Marketing Leads; with commercial performance support
Operate in a matrix — lead and influence enabling functions without direct reporting lines, including a semi-independent legal entity with its own field force within the cluster structure
Attract, develop, and retain talent; build leadership pipeline across geographies

Champion adoption of AI-enabled ways of working and fosters a culture of continuous learning and innovation
Demonstrate strong personal digital literacy and AI fluency, modelling practical use of data, digital tools, and AI-enabled solutions
Leverage technology, data, and AI-driven insights to inform strategy, accelerate decision making, and improve organizational performance
Leverage AI-driven dashboards for real-time cluster performance visibility and proactive resource reallocation
Identify and scale opportunities for automation, simplification, and digital transformation.
Ensure responsible use of AI through appropriate governance, risk awareness, and human oversight

Leading Through Change: Demonstrated experience leading leaders and teams through complex change, including navigating ambiguity, influencing across stakeholders, and sustaining performance during transformation
End-to-End Process Thinking: Proven ability to think and operate end-to-end, connecting strategy to execution across functions and anticipating downstream impacts to deliver integrated, enterprise-level solutions

The Cluster Lead holds full P&L accountability for the commercial business across various countries across Asia — a diverse set of markets spanning large-scale economies and established hubs, along high-growth markets within both contract and tender-driven environments. Distinguished by a plant-to-patient perspective, the role spans the full commercial value chain, from portfolio and pricing strategy through tender and contracting execution to patient access, across biosimilars and generics (Oncology, Immunology/Inflammation).
This is a build-and-shape mandate and the perfect opportunity for entrepreneurial leaders: the Cluster Lead will stand up a new cluster operating model from the ground up, setting strategic direction across in-market and launch assets while balancing standardization with calibration to local market realities.

Stakeholder management

Internal connections:
Optimizing internal connections and resources to bring the best value of others (other GH&B Cluster leads, Access & Value, Corporate Affairs, Global and HQ) to create a collaborative expanded network
External connections:
Lead the conversation with key stakeholders to strengthen Pfizer Position, reputation and purpose. Influencing and building trust /productive external partnerships with governments, regulatory agencies, Pharma industry associations, payers and/or HCPs

Bachelor's degree required; MBA or relevant advanced degree preferred
12+ years commercial experience in healthcare/pharma, including P&L management and multi-market leadership
Significant commercial experience in biosimilars, generics, or established brands required
Fluency in English required; additional Asian language skills an asset
Demonstrated ability to lead across diverse regulatory systems and market archetypes, ideally with knowledge of the Asian access landscape including government tender processes, partner/distributor models, and fragmented hospital markets
Track record of building commercial capabilities in scaling organizations

Bonus points if you have (preferred requirements)

Master's degree with relevant pharmaceutical industry experience
Leadership experience in one or more Asian markets
Transformation experience, particularly in technology enabled ways of working
Ability to build and leverage constructive relationships across various divisions
Experience in leading cross-functional teams
Strategic thinking and innovative mindset
Strong negotiation and influencing skills

Work location: Hybrid
Last date to apply: September 11, 2026
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers .

Mkt & Sales/Commercial Bus